@vik_bajaj
“What we don’t want to do is change just one little vertical silo,” ARCH's @rtnarch told us. “We can think, and have the resources to think, horizontally about the whole system.”View quoted post on X
Why ARCH is contributing over $200 million to Xaira:
endpts.com/archs-bob-nels…
endpoints.news Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D A star-studded mix of venture capitalists and scientists, backed by more than a billion dollars, is launching an ambitious biotech that aims to reinvent drug R&D using artificial intelligence, the ... We are elated to welcome Mary Helen Black to Foresite Labs! Mary Helen joins us as VP, Head of Human Genomics, leading a team focused on developing computational platforms leveraging large-scale clinical and genomic data to support new and early ventures.View quoted post on X
